Active fixed income ETFs from Hartford funds. Built to help you navigate complex bond markets with the affordability of an ETF.

Actively managing your fixed income is actively managing your client's future. Learn more at Hertfordfunds.com slash active.

Investing involves risk. Carefully consider funds investment objectives risk charges and expenses before

investing visit herford funds.com to obtain a prospectus containing this and other information read it

carefully before investing alps distributors here's your closing bell brief for tuesday july 22nd

i'm charlottnberg for the wall July 22nd. I'm Charlotte Gartenberg for the Wall Street Journal.

U.S. stock indexes ended mixed today as the U.S. reached trade packs with the Philippines and Indonesia,

and blue chip earnings continue to roll in. The Dow Jones Industrial Average rose 179 points to close at 44,502, the S&P 500 edged up four points, and the NASDAQ fell 81 points.

After new tariff pacts, investors await other trade updates ahead of the White House's August 1st tariff deadline.

Meanwhile, Treasury Secretary Scott Bessent said Federal Reserve Chair Jerome Powell

should finish out his term if he so decides. Among individual companies, shares and retailer

coals jumped as investors discussed whether it was the next meme stock. The heavily shorted shares

are still down nearly 30 percent over the past year. Coal's shares ended the day up 38%.

Coca-Cola reported mixed quarterly results but raised its annual earnings outlook. The soda maker

confirmed it will roll out a cane sugar coke option. Its stock was down about half a percent

closing. Philip Morris's quarterly revenue mis forecasts,

and it shipped fewer tins of its popular nicotine pouches in than expected. Its shares were down

over 8%. Lockhe Martin's quarterly profit was hit by more than $1.7 billion in charges last quarter.

The defense company's stock slid 11%. General Motors,

the largest U.S. automaker, saw net income shrink 35% last quarter as tariffs weighed on the company.

Shares fell 8%. And pharmaceutical company, AstraZeneca, plans to invest $50 billion in the U.S. by 2030,

the latest drug maker to commit to American manufacturing ahead of threatened tariffs. shares rose 2.6% in the U.S. We'll have a lot more coverage

...